Supported by the Crohn's & Colitis Foundation of America through a generous gift from the Litwin Foundation, the Broad Medical Research Program, the Integrative Morphology core of the National Institutes of Health (NIH)-supported Cincinnati Children's Hospital Research Foundation Digestive Health Center (1P30DK078392-01), NIH grants R01 DK078683 (to LD.), DK068164 (to L.D.), and T32 DK007727 (to S.D., A.T.), and a VA Merit Review grant (to S.F.).
Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis†
Version of Record online: 18 FEB 2011
Copyright © 2011 Crohn's & Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 2, pages 236–245, February 2012
How to Cite
D'Mello, S., Trauernicht, A., Ryan, A., Bonkowski, E., Willson, T., Trapnell, B. C., Frank, S. J., Kugasathan, S. and Denson, L. A. (2012), Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis. Inflamm Bowel Dis, 18: 236–245. doi: 10.1002/ibd.21689
- Issue online: 10 JAN 2012
- Version of Record online: 18 FEB 2011
- Manuscript Accepted: 19 JAN 2011
- Manuscript Received: 29 DEC 2010
Additional Supporting Information may be found in the online version of this article.
|IBD_21689_sm_suppinfotables.doc||65K||Supporting Table I: Disease Location at Diagnosis Supporting Table II: Disease Activity and Growth Following Diagnosis Supporting Table III: Disease Activity at Time of Blood Sampling Supporting Table IV: Medication Exposures at Time of Blood Sampling Supporting Table V: Determinants of Small Bowel Location Supporting Table VI: Determinants of Weight Z Score|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.